Volker Straub Selected Research

protein O-mannose beta-1,2-N-acetylglucosaminyltransferase

5/2024	Expert Panel Curation of 31 Genes in Relation to Limb Girdle Muscular Dystrophy.
11/2008	Brain involvement in muscular dystrophies with defective dystroglycan glycosylation.
3/2003	Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease.
3/2002	Deficiency of alpha-dystroglycan in muscle-eye-brain disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Volker Straub Research Topics

Disease

54	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2024 - 07/2002
38	Muscular Dystrophies (Muscular Dystrophy) 02/2024 - 03/2002
36	Muscular Diseases (Myopathy) 05/2024 - 10/2002
21	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 11/2022 - 11/2004
16	Muscle Weakness 02/2024 - 08/2007
12	Disease Progression 08/2023 - 01/2013
10	Glycogen Storage Disease Type II (Pompe's Disease) 05/2022 - 07/2013
9	Rare Diseases (Rare Disease) 11/2023 - 01/2013
9	Cardiomyopathies (Cardiomyopathy) 12/2019 - 05/2009
7	Fibrosis (Cirrhosis) 01/2023 - 05/2009
6	Inborn Genetic Diseases (Disease, Hereditary) 03/2024 - 01/2008
6	Dysferlinopathy 01/2023 - 12/2005
5	type 2B Limb-girdle muscular dystrophy 11/2022 - 06/2007
5	Sarcoglycanopathies 01/2022 - 12/2008
5	Bethlem myopathy 01/2020 - 12/2013
4	Respiratory Insufficiency (Respiratory Failure) 12/2023 - 03/2014
4	Scleroatonic muscular dystrophy 01/2020 - 01/2013
4	Limb-girdle muscular dystrophy type 2A 01/2020 - 12/2007
4	Type 2I Limb-Girdle Muscular Dystrophy 01/2020 - 01/2005
4	Neuromuscular Diseases (Neuromuscular Disease) 01/2020 - 11/2013
4	Distal Myopathies (Distal Muscular Dystrophy) 11/2017 - 07/2008
4	Miyoshi myopathy 09/2010 - 03/2007
3	Muscle Hypotonia (Hypotonia) 10/2021 - 02/2012
3	Walker-Warburg Syndrome 01/2020 - 03/2002
3	Scoliosis 01/2017 - 02/2012
3	Limb-girdle muscular dystrophy type 2F 01/2013 - 12/2008
3	Ophthalmoplegia (External Ophthalmoplegia) 09/2011 - 08/2007
2	Facies 02/2024 - 10/2021
2	Proteostasis Deficiencies 10/2023 - 01/2020
2	Motor Neuron Disease (Primary Lateral Sclerosis) 10/2023 - 07/2021
2	Frontotemporal Dementia (Semantic Dementia) 10/2023 - 01/2022
2	Inflammation (Inflammations) 09/2023 - 01/2021
2	Vacuolar myopathy 01/2023 - 07/2013
2	Dyslipidemias (Dyslipidemia) 11/2022 - 07/2020
2	Muscular Atrophy (Muscle Atrophy) 11/2022 - 01/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 07/2021
2	Osteoporosis 01/2022 - 01/2021
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 10/2021 - 11/2020
2	Left Ventricular Dysfunction 01/2021 - 05/2009
2	Camptocormia 01/2021 - 06/2013
2	Intellectual Disability (Idiocy) 11/2020 - 03/2017
2	Cataract (Cataracts) 05/2017 - 03/2017
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2014 - 09/2009
2	Myasthenia Gravis 04/2014 - 03/2011
2	Myofibrillar Myopathy 03/2014 - 05/2009
2	Hereditary Myopathy with Early Respiratory Failure 03/2014 - 06/2012
2	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 09/2013 - 02/2012
2	Malignant Hyperthermia 06/2013 - 08/2007
2	1 Rippling muscle disease 03/2011 - 07/2008

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2004
24	DystrophinIBA 01/2023 - 05/2009
14	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2013
13	Creatine Kinase (Creatine Phosphokinase)IBA 12/2023 - 01/2005
11	DysferlinIBA 12/2022 - 12/2005
9	Sarcoglycans (beta Sarcoglycan)IBA 08/2023 - 12/2008
9	CollagenIBA 01/2021 - 11/2009
8	GlucocorticoidsIBA 03/2024 - 01/2016
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 11/2009
8	Dystroglycans (Dystroglycan)IBA 01/2018 - 03/2002
6	ConnectinIBA 03/2024 - 06/2012
6	GlucosidasesIBA 05/2022 - 07/2013
6	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2013 - 06/2002
5	Antisense OligonucleotidesIBA 01/2023 - 01/2014
5	AcidsIBA 05/2022 - 07/2016
5	GlycogenIBA 05/2022 - 01/2016
5	AntibodiesIBA 11/2021 - 12/2007
5	CalciumIBA 01/2020 - 08/2007
4	protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA 05/2024 - 03/2002
4	EnzymesIBA 01/2023 - 01/2021
4	human GAA protein (Myozyme)FDA Link 12/2021 - 01/2015
4	SteroidsIBA 01/2021 - 05/2009
4	CalpainIBA 01/2020 - 12/2007
3	Prednisone (Sone)FDA LinkGeneric 03/2024 - 01/2022
3	RNA (Ribonucleic Acid)IBA 02/2024 - 04/2016
3	Testosterone (Sustanon)FDA Link 09/2023 - 12/2015
3	MyostatinIBA 01/2023 - 05/2008
3	golodirsenIBA 01/2022 - 01/2020
3	MorpholinosIBA 01/2021 - 10/2009
3	MicroRNAs (MicroRNA)IBA 11/2020 - 01/2013
3	eteplirsenIBA 10/2012 - 10/2009
2	VBP15 compoundIBA 03/2024 - 10/2022
2	Muscle Proteins (Muscle Protein)IBA 03/2024 - 03/2011
2	ElementsIBA 11/2023 - 10/2023
2	Valosin Containing ProteinIBA 10/2023 - 01/2020
2	deflazacortIBA 01/2022 - 01/2020
2	EP3533IBA 01/2021 - 01/2019
2	Contrast MediaIBA 01/2021 - 12/2004
2	Troponin IIBA 01/2021 - 09/2015
2	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 01/2020 - 07/2014
2	2,2,2',4'-tetrachloroacetophenoneIBA 01/2020 - 04/2015
2	Phosphotransferases (Kinase)IBA 01/2017 - 03/2014
2	Myosin Light Chains (Myosin Essential Light Chain)IBA 09/2015 - 07/2014
2	Fibronectins (Fibronectin)IBA 04/2014 - 03/2014
2	Calcium Channels (Calcium Channel)IBA 01/2013 - 01/2011
2	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2013 - 11/2010
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2011 - 07/2002
2	Caveolin 3IBA 03/2011 - 07/2008

Therapy/Procedure

26	Therapeutics 11/2022 - 11/2010
4	Enzyme Replacement Therapy 05/2022 - 07/2013
2	Noninvasive Ventilation 05/2017 - 12/2013